title: Plethysmographic evaluation of the vascular effects of human calcitonin gene-related peptide in man.
abstract: Calcitonin gene-related peptide (CGRP) is a neuropeptide with potent cardiovascular effects that include positive inotropic and chronotropic actions systemic vasodilation, and hypotension in animals and in man. The mechanism of action of CGRP is still, however, not clear, and in particular it is not known whether vasodilation by CGRP occurs by changes in cutaneous or in muscular blood flow, or both. The aim of the study was, therefore, to evaluate the cutaneous and muscular blood flow, at rest and after ischemic test, induced by an IV bolus 25 micrograms human CGRP infusion in 5 healthy normotensive volunteers, using a strain gauge plethysmographic procedure with venous occlusion. Human CGRP provoked a transient but significant decrease in systolic and diastolic blood pressure, associated with tachycardia, marked flushing, a significant increase in plasma noradrenaline, adrenaline, and cyclic AMP levels, and a slight, but significant, decrease in serum total calcium. Moreover, a significant increase in the carpal cutaneous blood flow at rest was observed, with no significant change in the lower extremity muscular blood flow at rest and after ischemic test. Finally human CGRP produced a significant increase in the venous partial O2 pressure and in the hematocrit and a significant decrease in the venous partial CO2 pressure. The results of the present study confirm the acute cardiovascular and metabolic effects of CGRP. In fact, hypotension, tachycardia, flushing, and the increased cutaneous blood flow indicate a systemic vasodilation by the neuropeptide, with a secondary sympathetic response, as documented by the augmented catecholamine and cyclic AMP plasma levels.
authors.affiliation: Institute of Medical Semeiotics, University of Siena, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Gennari
authors.forename: R
authors.initials: R
authors.lastname: Nami
authors.forename: S
authors.initials: S
authors.lastname: Pecchi
authors.forename: V
authors.initials: V
authors.lastname: De Franco
authors.forename: F
authors.initials: F
authors.lastname: Panza
authors.forename: G
authors.initials: G
authors.lastname: Pavese
mesh_terms: D015740:Calcitonin Gene-Related Peptide / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000098:blood supply; D010991:Plethysmography; D012039:Regional Blood Flow / Q000187:drug effects; D012867:Skin / Q000098:blood supply; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents
chemical_list: D014665:Vasodilator Agents; D015740:Calcitonin Gene-Related Peptide